☆ 4.6 Editorial Material

SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England

JOURNAL OF CLINICAL VIROLOGY (2020)

Journal

JOURNAL OF CLINICAL VIROLOGY

Volume 129, Issue -, Pages -

Publisher

ELSEVIER

DOI: 10.1016/j.jcv.2020.104545

Keywords

-

Categories

Virology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Immunology

Antibody Response to COVID-19 Booster Vaccination in Healthcare Workers

Arianna Pani, Alessandra Romandini, Alice Schianchi, Michele Senatore, Oscar M. Gagliardi, Gianluca Gazzaniga, Stefano Agliardi, Tommaso Conti, Paolo A. Schenardi, Matteo Maggi, Stefano D'Onghia, Valentina Panetta, Silvia Renica, Silvia Nerini Molteni, Chiara Vismara, Daniela Campisi, Michaela Bertuzzi, Simona Giroldi, Laura Zoppini, Mauro Moreno, Marco Merli, Marco Bosio, Massimo Puoti, Francesco Scaglione

Summary: This study evaluated the increase in antibody titers 14 days after the booster dose of BNT162b2. The results showed a potent universal antibody response regardless of pre-booster vaccine seronegativity.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine

Jae Hong Choi, Young Ree Kim, Sang Taek Heo, Hyunjoo Oh, Misun Kim, Hyang Ran Lee, Jeong Rae Yoo

Summary: In this study, the antibody response of healthcare workers after BNT162b2 mRNA COVID-19 vaccination was evaluated. The vaccine was found to be effective in protecting healthcare personnel, but neutralizing antibody levels gradually declined over a period of 6 months after the second dose, suggesting the need for a booster vaccination after 6 months of full vaccination.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Victoria Jane Hall, Sarah Foulkes, Andre Charlett, Ana Atti, Edward J. M. Monk, Ruth Simmons, Edgar Wellington, Michelle J. Cole, Ayoub Saei, Blanche Oguti, Katie Munro, Sarah Wallace, Peter D. Kirwan, Madhumita Shrotri, Amoolya Vusirikala, Sakib Rokadiya, Meaghan Kall, Maria Zambon, Mary Ramsay, Tim Brooks, Colin S. Brown, Meera A. Chand, Susan Hopkins

Summary: This study investigated whether antibodies against SARS-CoV-2 were associated with a decreased risk of symptomatic and asymptomatic reinfection. It found that individuals with a previous history of SARS-CoV-2 infection had an 84% lower risk of reinfection, with a median protective effect lasting for 7 months following primary infection.

LANCET (2021)

Add to Collection

Article Infectious Diseases

Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia

Cucunawangsih Cucunawangsih, Ratna Sari Wijaya, Nata Pratama Hardjo Lugito, Ivet Suriapranata

Summary: Fully-vaccinated healthcare workers had a high rate of seroconversion of anti-S antibodies after 14 days of receiving the inactivated SARS-CoV-2 vaccine, but the levels decreased by day 42 and persisted up to day 98 post-vaccination. Those with prior SARS-CoV-2 infection had significantly higher and stable levels of anti-S antibodies. This study suggests the need for a potential booster dose for HCWs without prior infection to enhance protection against COVID-19.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic

Helen Ward, Christina Atchison, Matthew Whitaker, Kylie E. C. Ainslie, Joshua Elliott, Lucy Okell, Rozlyn Redd, Deborah Ashby, Christl A. Donnelly, Wendy Barclay, Ara Darzi, Graham Cooke, Steven Riley, Paul Elliott

Summary: The REACT-2 study in England found that by mid-July 2020, around 6% of adults had been infected with SARS-CoV-2, with healthcare workers and individuals of Black or South Asian ethnicity disproportionately affected. Although different ethnicities had similar infection fatality ratios, higher hospitalization and mortality rates in minority ethnic groups may be due to higher rates of infection rather than differential disease experience or care.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Immunology

COVID-19 Symptoms and Deaths among Healthcare Workers, United States

Shao Lin, Xinlei Deng, Ian Ryan, Kai Zhang, Wangjian Zhang, Ese Oghaghare, DeeDee Bennett Gayle, Benjamin Shaw

Summary: Age, gender, and race are associated with the risk of COVID-19 death among healthcare workers. Severe clinical indicators and specific symptoms can predict COVID-19-related deaths in healthcare workers.

EMERGING INFECTIOUS DISEASES (2022)

Add to Collection

Article Medicine, General & Internal

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

S. F. Lumley, D. O'Donnell, N. E. Stoesser, P. C. Matthews, A. Howarth, S. B. Hatch, B. D. Marsden, S. Cox, T. James, F. Warren, L. J. Peck, T. G. Ritter, Z. de Toledo, L. Warren, D. Axten, R. J. Cornall, E. Y. Jones, D. I. Stuart, G. Screaton, D. Ebner, S. Hoosdally, M. Chand, D. W. Crook, A. -M. O'Donnell, C. P. Conlon, K. B. Pouwels, A. S. Walker, T. E. A. Peto, S. Hopkins, T. M. Walker, K. Jeffery, D. W. Eyre

Summary: In a longitudinal study of seropositive and seronegative health care workers undergoing asymptomatic and symptomatic SARS-CoV-2 testing, the presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

Homologous booster immunization with an inactivated vaccine induced robust antibody response in healthcare workers: A retrospective study

Gui-Ping Wen, Min Zhu, Li-Rong Li, Xiu-Juan Li, Hui-Ming Ye, Yu-Lin Zhou

Summary: Coronavirus Disease 2019 (Covid-19) has had severe impacts on global health, society, and economy. To combat the spread of SARS-CoV-2 variants and the waning efficacy of primary vaccination, a Covid-19 booster vaccination is being implemented worldwide. This study evaluated the antibody response and immune persistence of the homologous BBIBP-CorV booster vaccination within 6 months. The results showed that the third dose induced a robust antibody response and moderate immune persistence, unaffected by age or sex.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Immunology

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers

Sheila F. Lumley, Jia Wei, Denise O'Donnell, Nicole E. Stoesser, Philippa C. Matthews, Alison Howarth, Stephanie B. Hatch, Brian D. Marsden, Stuart Cox, Tim James, Liam J. Peck, Thomas G. Ritter, Zoe de Toledo, Richard J. Cornall, E. Yvonne Jones, David Stuart, Gavin Screaton, Daniel Ebner, Sarah Hoosdally, Derrick W. Crook, Christopher P. Conlon, Koen B. Pouwels, A. Sarah Walker, Tim E. A. Peto, Timothy M. Walker, Katie Jeffery, David W. Eyre

Summary: In this study, it was found that anti-nucleocapsid antibodies against SARS-CoV-2 decline within a few months, with higher titers associated with longer duration. On the other hand, anti-spike IgG remained stably detected. Factors such as age, ethnicity, and symptom presentation also had an impact on antibody levels.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

SARS-CoV-2 Antibody Dynamics in Healthcare Workers after mRNA Vaccination

Kevin D. Dieckhaus, Min-Jung Kim, Jian-Bing Shen, Tina S. Liang, Michael J. Kleinberg, Kristen M. Siedlarz, David B. Banach, Mark L. Metersky, Rob P. Fuller, Eric M. Mortensen, Bruce T. Liang

Summary: Since the emergence of SARS-CoV-2, maintaining the health and safety of healthcare workers has been crucial in addressing the global pandemic. Vaccination with mRNA-based vaccines targeting the spike protein of SARS-CoV-2 has been identified as an important strategy in reducing the susceptibility of healthcare workers to the virus. However, neutralizing antibody responses may decrease over time and can be influenced by various factors. This study aimed to examine the relationship between vaccine products, prior clinical illness from SARS-CoV-2, vaccine-associated adverse reactions, and the decay of antibodies over time in healthcare workers at a university medical center. The findings showed that vaccination with mRNA-1273 resulted in more sustained antibody responses compared to bnt162b2. Individuals who experienced vaccine-associated symptoms were more likely to have a prolonged neutralizing antibody response. Those who had previous clinical infection with SARS-CoV-2 before vaccination were more likely to experience vaccine-associated symptoms after the first dose and had a less significant decline in antibodies. Understanding these factors can assist clinicians in determining effective vaccine strategies for healthcare workers.

VACCINES (2023)

Add to Collection

Article Immunology

BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers

Federico Pratesi, Teresita Caruso, Davide Testa, Tiziano Tarpanelli, Alessandra Gentili, Davide Gioe, Paola Migliorini

Summary: The study found that the BNT162b2 vaccine can induce high levels of antibody response in vaccinated individuals, including IgG and IgA antibodies, as well as antibodies with high avidity. Additionally, the research indicates that levels of neutralizing antibodies significantly increase after the booster dose of the BNT162b2 vaccine.

VACCINES (2021)

Add to Collection

Article Immunology

Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers

Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Ronit Almog, Ronit Leiba, Avi Weissman, Michal Mekel, Gila Hyams, Nethanel A. Horowitz, Vardit Gepstein, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Yael Shachor-Meyouhas

Summary: This study assessed the humoral response to the third BNT162b2 dose among healthcare workers. The results showed that the third booster dose had a positive effect on enhancing immunogenicity, with higher antibody concentrations among tested healthcare workers. Age, heart disease, immunodeficiency, and smoking were significantly associated with decreased antibody concentrations, while female sex was associated with increased antibody concentrations.

VACCINES (2022)

Add to Collection

Article Medicine, General & Internal

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

Moriah Bergwerk, Tal Gonen, Yaniv Lustig, Sharon Amit, Marc Lipsitch, Carmit Cohen, Michal Mandelboim, Einav Gal Levin, Carmit Rubin, Victoria Indenbaum, Ilana Tal, Malka Zavitan, Neta Zuckerman, Adina Bar-Chaim, Yitshak Kreiss, Gili Regev-Yochay

Summary: Among fully vaccinated health care workers, breakthrough infections with SARS-CoV-2 were correlated with neutralizing antibody titers during the peri-infection period. Most breakthrough infections were mild or asymptomatic, although persistent symptoms did occur.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

Antibodies to NCP, RBD and S2 SARS-CoV-2 in Vaccinated and Unvaccinated Healthcare Workers

Agata Blaszczuk, Aleksander Michalski, Maria Malm, Bartlomiej Drop, Malgorzata Polz-Dacewicz

Summary: The study aimed to determine the seroprevalence and titer of anti-SARS-CoV-2 IgG antibodies in vaccinated and unvaccinated healthcare workers. Results indicated that the highest seroprevalence and antibody titer were in the COVID-19 Vaccinated group. Multiple vaccinations and continuous testing are recommended for maintaining a high level of antibodies.

VACCINES (2022)

Add to Collection

Article Virology

Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study

Tugba Y. Yalcin, Deniz Topcu, Ozlem Dogan, Saliha Aydin, Nuran Sari, Cigdem Erol, Zeynep E. Kuloglu, Ozlem K. Azap, Fusun Can, Hande Arslan

Summary: This study evaluated antibody levels after inactivated virus vaccination, finding that individuals previously infected with COVID-19 had higher antibody levels and longer duration of antibody response after a single vaccine dose. A positive correlation between IgGsp antibody titers and neutralizing capacity was also observed, suggesting that quantitative IgGsp values may reflect vaccine neutralization capacity.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Clinical Neurology

The effect of level of injury and physical activity on heart rate variability following spinal cord injury

Athanasios Kyriakides, Dimitrios Poulikakos, Angeliki Galata, Dimitrios Konstantinou, Elias Panagiotopoulos, Elisabeth Chroni

JOURNAL OF SPINAL CORD MEDICINE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of QRS-T angle and heart rate variability with major cardiac events and mortality in hemodialysis patients

Dimitrios Poulikakos, Katerina Hnatkova, Debasish Banerjee, Marek Malik

ANNALS OF NONINVASIVE ELECTROCARDIOLOGY (2018)

Add to Collection

Article Primary Health Care

Improved management of acute kidney injury in primary care using e-alerts and an educational outreach programme

James Tollitt, Emma Flanagan, Sheila McCorkindale, Sam Glynn-Atkins, Lauren Emmett, Denise Darby, James Ritchie, Brandon Bennett, Smeeta Sinha, Dimitrios Poulikakos

FAMILY PRACTICE (2018)

Add to Collection

Review Transplantation

The potential of electrocardiography for cardiac risk prediction in chronic and end-stage kidney disease

Sofia Skarnpardoni, Dirnitrios Poulikakos, Marek Malik, Darren Green, Philip A. Kalra

NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)

Add to Collection

Review Physiology

Sudden Cardiac Death in Dialysis: Arrhythmic Mechanisms and the Value of Non-invasive Electrophysiology

Dimitrios Poulikakos, Katerina Hnatkova, Sofia Skampardoni, Darren Green, Philip Kalra, Marek Malik

FRONTIERS IN PHYSIOLOGY (2019)

Add to Collection

Article Physiology

QRS-T Angle Predicts Cardiac Risk and Correlates With Global Longitudinal Strain in Prevalent Hemodialysis Patients

Sofia Skampardoni, Darren Green, Katerina Hnatkova, Marek Malik, Philip A. Kalra, Dimitrios Poulikakos

FRONTIERS IN PHYSIOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

The importance of acute kidney injury in suspected community acquired infection

James Tollitt, Nicola Bennett, Denise Darby, Emma Flanagan, Paul Chadwick, Smeeta Sinha, Philip A. Kalra, James Ritchie, Dimitrios Poulikakos

PLOS ONE (2019)

Add to Collection

Correction Transplantation

The potential of electrocardiography for cardiac risk prediction in chronic and end-stage kidney disease (vol 34, pg 1089, 2018)

Sofia Skampardoni, Dimitrios Poulikakos, Marek Malik, Darren Green, Philip A. Kalra

NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)

Add to Collection

Letter Public, Environmental & Occupational Health

Increased risk of COVID-19 in haemodialysis healthcare workers in a tertiary centre in the North West of England

S. Gray, T. Clough, Y. Mcgee, T. Murphy, D. Poulikakos

JOURNAL OF HOSPITAL INFECTION (2020)

Add to Collection

Article Urology & Nephrology

Safely reducing haemodialysis frequency during the COVID-19 pandemic

Michelle Da Silva Lodge, Thilini Abeygunaratne, Helen Alderson, Ibrahim Ali, Nina Brown, Constantina Chrysochou, Rosie Donne, Ibi Erekosima, Philip Evans, Emma Flanagan, Simon Gray, Darren Green, Janet Hegarty, Audrey Hyde, Philip A. Kalra, Elizabeth Lamerton, David Lewis, Rachel Middleton, David New, Robert Nipah, Donal O'Donoghue, Edmond O'Riordan, Dimitrios Poulikakos, Francesco Rainone, Maharajan Raman, James Ritchie, Smeeta Sinha, Grahame Wood, J. Tollitt

BMC NEPHROLOGY (2020)

Add to Collection

Article Urology & Nephrology

Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom

Olivia Wickens, Rajkumar Chinnadurai, Fahmida Mannan, Frida Svendsen, Mirza Yasar Baig, Chukwuma Chukwu, Ibrahim Ali, Christina Summersgill, Dawn Evans, Berckley V. Antoine, Julie Oxton, Nathan Mairs, Emma Flanagan, Robert Oliver, Philip A. Kalra, Dimitrios Poulikakos

Summary: This study aimed to investigate the duration of host immunity and the role of serological testing in ESRD patients receiving haemodialysis who tested positive for COVID-19. The results showed that antibody response can be detected at least 7 months after COVID-19 infection, providing hope for similar protection with approved vaccines.

BMC NEPHROLOGY (2021)

Add to Collection

Letter Urology & Nephrology

Travel arrangements in hemodialysis patients during the COVID-19 pandemic including London-style black cabs for transfer to a designated isolation unit

Victoria Fox, Dimitrios Poulikakos

HEMODIALYSIS INTERNATIONAL (2021)

Add to Collection

Article Urology & Nephrology

A pilot project evaluating a fixed drainage system (U-Drain) for automated peritoneal dialysis

Dimitrios Poulikakos, Joanne Martin, Joanne Collier, David Lewis

Summary: U-Drain is a fixed drainage system for automated peritoneal dialysis that connects dialysis effluent outflow directly to the household drainage system, avoiding the use of drain bags. The pilot project showed increased patient satisfaction and an acceptable safety profile for the U-Drain technology.

PERITONEAL DIALYSIS INTERNATIONAL (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Occupational exposure of healthcare workers to COVID- 19 and infection prevention control measures in haemodialysis facilities in North West of England

Simon Gray, Toni Clough, Yvonne Mcgee, Tracey Murphy, Rosemary Donne, Dimitrios Poulikakos

Summary: COVID-19 infection rates are high in haemodialysis facilities due to comorbidities and frequent treatment attendance. In order to reduce transmission and occupational exposure risk, IPC measures were implemented in a renal center.

INFECTION PREVENTION IN PRACTICE (2021)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.